Lily Tang

1.0k total citations
44 papers, 788 citations indexed

About

Lily Tang is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Lily Tang has authored 44 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 8 papers in Physiology. Recurrent topics in Lily Tang's work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Lily Tang is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Lily Tang collaborates with scholars based in United States, China and United Kingdom. Lily Tang's co-authors include George C. Cotzias, Samuel T. Miller, James Z. Ginos, Paul S. Papavasiliou, Eduardo Tolosa, Dale T. Umetsu, Suwat Benjaponpitak, Rosemarie H. DeKruyff, Lucille S. Hurley and Kathy Keller and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Lily Tang

43 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lily Tang United States 17 213 191 136 101 80 44 788
K. Nandy United States 16 178 0.8× 166 0.9× 87 0.6× 188 1.9× 102 1.3× 55 797
Nadir Arıcan Türkiye 20 175 0.8× 139 0.7× 97 0.7× 87 0.9× 97 1.2× 56 917
Caroline Dalton United Kingdom 21 305 1.4× 177 0.9× 128 0.9× 152 1.5× 50 0.6× 71 1.4k
N. Callaghan Ireland 16 109 0.5× 180 0.9× 54 0.4× 209 2.1× 72 0.9× 40 1.2k
Paul Maertens United States 13 217 1.0× 96 0.5× 105 0.8× 49 0.5× 27 0.3× 36 773
Marta Kowalska Poland 18 255 1.2× 138 0.7× 93 0.7× 175 1.7× 42 0.5× 66 961
Leonard G. Davis United States 18 395 1.9× 333 1.7× 37 0.3× 99 1.0× 49 0.6× 43 1.0k
Deshandra M. Raidoo South Africa 19 242 1.1× 145 0.8× 62 0.5× 161 1.6× 51 0.6× 38 1.2k
Roberta Verde Italy 22 302 1.4× 233 1.2× 61 0.4× 189 1.9× 43 0.5× 41 1.4k
J. Edward Fisher United States 20 174 0.8× 416 2.2× 102 0.8× 63 0.6× 45 0.6× 41 1.1k

Countries citing papers authored by Lily Tang

Since Specialization
Citations

This map shows the geographic impact of Lily Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Tang more than expected).

Fields of papers citing papers by Lily Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lily Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Tang. The network helps show where Lily Tang may publish in the future.

Co-authorship network of co-authors of Lily Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Lily Tang. A scholar is included among the top collaborators of Lily Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lily Tang. Lily Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srour, Samer A., Jad Chahoud, Alexandra Drakaki, et al.. (2025). ALLO-316 in advanced clear cell renal cell carcinoma (ccRCC): Updated results from the phase 1 TRAVERSE study.. Journal of Clinical Oncology. 43(16_suppl). 4508–4508. 4 indexed citations
2.
Trajano, Gabriel S., et al.. (2023). Longitudinal changes in intrinsic motoneuron excitability in amyotrophic lateral sclerosis are dependent on disease progression. The Journal of Physiology. 601(21). 4723–4735. 10 indexed citations
3.
Patel, Seema, Robert Hinch, Lily Tang, et al.. (2022). Large-scale calibration and simulation of COVID-19 epidemiologic scenarios to support healthcare planning. Epidemics. 42. 100662–100662. 7 indexed citations
4.
Lu, Hongtao, Dawei Sun, Jinhui Zhang, et al.. (2021). 792 Creating an immune-favorable tumor microenvironment by a novel anti-CD39/TGFβ-Trap bispecific antibody. SHILAP Revista de lepidopterología. A827–A827. 1 indexed citations
5.
Bai, Xue, Daniel Wai‐Hung Ho, Karen Fung, et al.. (2014). Effectiveness of a life story work program on older adults with intellectual disabilities. Clinical Interventions in Aging. 9. 1865–1865. 18 indexed citations
6.
Li, Jing, Barry R. Davies, Sufang Han, et al.. (2013). The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere. Journal of Translational Medicine. 11(1). 241–241. 61 indexed citations
7.
Tang, Lily, et al.. (2008). A rapid two dot filter assay for the detection of E. coli O157 in water samples. Journal of Immunological Methods. 336(2). 159–165. 10 indexed citations
8.
Tang, Lily, et al.. (2001). Pylephlebitis, portal-mesenteric thrombosis, and multiple liver abscesses owing to perforated appendicitis. Journal of Pediatric Surgery. 36(9). 19–21. 38 indexed citations
9.
Tang, Lily, Suwat Benjaponpitak, Rosemarie H. DeKruyff, & Dale T. Umetsu. (1998). Reduced prevalence of allergic disease in patients with multiple sclerosis is associated with enhanced IL-12 production. Journal of Allergy and Clinical Immunology. 102(3). 428–435. 28 indexed citations
10.
Tang, Lily. (1995). Perspective of Neurochemistry in Neurological Disorders. Advances in experimental medicine and biology. 363. 1–13. 1 indexed citations
11.
Zhao, Xueying, et al.. (1995). Advances in Clinical Research on Common Mental Disorders with Computer Controlled Electro-Acupuncture Treatment. Advances in experimental medicine and biology. 363. 109–122. 8 indexed citations
12.
Tang, Lily. (1991). Human erythrocyte as a model for investigating muscarinic agonists and antagonists. General Pharmacology The Vascular System. 22(3). 485–490. 9 indexed citations
13.
Chock, Stephen P., et al.. (1991). Linking phospholipase A2 to phospholipid turnover and prostaglandin synthesis in mast cell granules. European Journal of Biochemistry. 195(3). 707–713. 13 indexed citations
14.
Tang, Lily. (1987). The modulation of dopamine-sensitive adenylate cyclase activity in the mouse caudate nucleus by estradiol. Brain Research. 405(1). 178–182. 4 indexed citations
15.
Cotzias, George C. & Lily Tang. (1977). An Adenylate Cyclase of Brain Reflects Propensity for Breast Cancer in Mice. Science. 197(4308). 1094–1096. 20 indexed citations
16.
Ginos, James Z., et al.. (1975). Cholinergic effects of molecular segments of apomorphine and dopaminergic effects of N,N-dialkylated dopamines. Journal of Medicinal Chemistry. 18(12). 1194–1200. 28 indexed citations
17.
Cotzias, George C., et al.. (1972). A Mutation Influencing the Transportation of Manganese, L-Dopa, and L-Tryptophan. Science. 176(4033). 410–412. 36 indexed citations
18.
Cotzias, George C., Lily Tang, Samuel T. Miller, & James Z. Ginos. (1971). Melatonin and Abnormal Movements Induced by L-Dopa in Mice. Science. 173(3995). 450–452. 79 indexed citations
19.
Cotzias, George C., et al.. (1971). Block of Cerebral Actions of L-Dopa with Methyl Receptor Substances. Nature. 231(5304). 533–535. 22 indexed citations
20.
Cotzias, George C., Paul S. Papavasiliou, Edwin R. Hughes, Lily Tang, & Donald C. Borg. (1968). Slow turnover of manganese in active rheumatoid arthritis accelerated by prednisone. Journal of Clinical Investigation. 47(5). 992–1001. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Nandy Breakdown of academic impact, for papers by Nadir Arıcan Breakdown of academic impact, for papers by Caroline Dalton Breakdown of academic impact, for papers by N. Callaghan Breakdown of academic impact, for papers by Paul Maertens Breakdown of academic impact, for papers by Marta Kowalska Breakdown of academic impact, for papers by Leonard G. Davis Breakdown of academic impact, for papers by Deshandra M. Raidoo Breakdown of academic impact, for papers by Roberta Verde Breakdown of academic impact, for papers by J. Edward Fisher
Rankless by CCL
2026